Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

RAPHAEL NOVOGRODSKY

Allopathic & Osteopathic Physicians Urology

NPI
1134161201
CMS profile
187256
Location
BRONX, NY

General Payments · PY2019–2025

$6,796.21

  • Reported across 102 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$277.84

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $277.84 15

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Sumitomo Pharma America, Inc. $188.72 12
Astellas Pharma US Inc $69.37 2
Teleflex LLC $19.75 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $5,477.32 34
PY2020 $191.98 10
PY2021 $157.11 8
PY2022 $254.65 14
PY2023 $310.44 15
PY2024 $126.87 6
PY2025 $277.84 15

Payment records · PY2025 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $34.72 10/16/2025 Food and Beverage Undisputed 06/30/2026 1238700334 CMS
Astellas Pharma US Inc $34.65 11/24/2025 Food and Beverage Undisputed 06/30/2026 1238581759 CMS
Sumitomo Pharma America, Inc. $14.83 01/09/2025 Food and Beverage Undisputed 06/30/2026 1176698926 CMS
Sumitomo Pharma America, Inc. $16.93 03/06/2025 Food and Beverage Undisputed 06/30/2026 1176698928 CMS
Sumitomo Pharma America, Inc. $20.10 04/09/2025 Food and Beverage Undisputed 06/30/2026 1176698930 CMS
Sumitomo Pharma America, Inc. $18.07 05/15/2025 Food and Beverage Undisputed 06/30/2026 1176698932 CMS
Sumitomo Pharma America, Inc. $5.41 06/04/2025 Food and Beverage Undisputed 06/30/2026 1176698934 CMS
Sumitomo Pharma America, Inc. $20.25 06/26/2025 Food and Beverage Undisputed 06/30/2026 1176698936 CMS
Sumitomo Pharma America, Inc. $2.00 06/26/2025 Food and Beverage Undisputed 06/30/2026 1176698938 CMS
Sumitomo Pharma America, Inc. $16.12 08/08/2025 Food and Beverage Undisputed 06/30/2026 1176698940 CMS
Sumitomo Pharma America, Inc. $21.11 10/02/2025 Food and Beverage Undisputed 06/30/2026 1176698942 CMS
Sumitomo Pharma America, Inc. $19.19 10/23/2025 Food and Beverage Undisputed 06/30/2026 1176698944 CMS
Sumitomo Pharma America, Inc. $15.80 11/20/2025 Food and Beverage Undisputed 06/30/2026 1176698946 CMS
Sumitomo Pharma America, Inc. $18.91 12/11/2025 Food and Beverage Undisputed 06/30/2026 1176698948 CMS
Teleflex LLC $19.75 11/06/2025 Food and Beverage Undisputed 06/30/2026 1242448934 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.